Author: Chu Yu-Waye Polson Andrew
Publisher: Future Medicine
ISSN: 1479-6694
Source: Future Oncology, Vol.9, Iss.3, 2013-03, pp. : 355-368
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By DiJoseph John Dougher Maureen Armellino Douglas Kalyandrug Lyka Kunz Arthur Boghaert Erwin Hamann Philip Damle Nitin
Cancer Immunology, Immunotherapy, Vol. 56, Iss. 7, 2007-07 ,pp. :
Pralatrexate: treatment of T-cell non-Hodgkin’s lymphoma
By Parker Terri Barbarotta Lisa Foss Francine
Future Oncology, Vol. 9, Iss. 1, 2013-01 ,pp. :
By Schütt P. Zimmermann K. Derks C. Ebeling P. Welt A. Poser M. Hense J. Metz K. Anhuf J. Sandmann M. Neise M. Moritz T. Stuschke M. Niederle N. Seeber S. Nowrousian Mohammad
Journal of Cancer Research and Clinical Oncology, Vol. 135, Iss. 3, 2009-03 ,pp. :
By Wang Bufei Huang Huiqiang Bu Qing Xia Zhongjun Lin Xubin Wang Fenghua Li Yuhong Peng Yulong Pan Zhanhe Wang Shusen Lin Tongyu Jiang Wenqi Guan Zhongzhen
The Chinese-German Journal of Clinical Oncology, Vol. 5, Iss. 6, 2006-12 ,pp. :